Skip to main content
SpringerLink
Log in

Transgenic Rabbits to Prepare Pharmaceutical Proteins

  • Chapter
Rabbit Biotechnology

Abstract

The preparation of recombinant pharmaceutical proteins is one of the major challenges of biotechnology. Mammalian cells are required for a number of proteins which must be modified posttranscriptionally. Animal cell lines cultured in fermentors are presently the major source of complex proteins. The milk of transgenic animals proved to be a possible source of pharmaceutical proteins and one of them, human antithrombin III, has been approved by the EU (EMEA) and US (FDA) medicament agencies. Several species are being implemented for this purpose. Rabbits are one of these species. It offers several advantages: low cost to produce transgenic founders, rapid reproduction, easy and cheap scaling up, easy breeding in pathogen-free conditions and insensitivity to prion diseases. Rabbits are thus an efficient tool to prepare several kilograms of a recombinant protein per year.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 129.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 169.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  • Bijvoet AG, Van Hirtum H, Kroos MA, Van de Kamp EH, Schoneveld O, Visser P, Brakenhoff JP, Weggeman M, van Corven EJ, Van der Ploeg AT, Reuser AJ. (1999) Human acid alpha- glucosidase from rabbit milk has therapeutic effect in mice with glycogen storage disease type II. Hum Mol Genet 8: 2145–2153.

    Article  PubMed  CAS  Google Scholar 

  • Bösze Zs, Houdebine LM. (2006) Application of rabbits in biomedical research: review. World Rabbit Sci 14: 1–14.

    Google Scholar 

  • Brem G, Hartl P, Besenfelder U, Wolf E, Zinovieva N, Pfaller R. (1994) Expression of synthetic cDNA sequences encoding human insulin-like growth factor-1 (IGF-1) in the mammary gland of transgenic rabbits. Gene 149: 351–355.

    Article  PubMed  CAS  Google Scholar 

  • Brem G, Besenfelder U, Zinovieva N, Seregi J, Solti L, Hartl P. (1995) Mammary gland specific expression of chymosin constructs in transgenic rabbits. Theriogenology 43: 175–175.

    Article  Google Scholar 

  • Buelow R, van Schooten W. (2006) The future of antibody therapy. Ernst Schering Found Symp Proc 4: 83–106.

    Article  PubMed  Google Scholar 

  • Buhler TA, Bruyere T, Went DF, Stranzinger G, Burki K. (1990) Rabbit beta-casein promoter directs secretion of human interleukin-2 into the milk of transgenic rabbits. Biotechnology (NY) 8: 140–143.

    Article  CAS  Google Scholar 

  • Chesné P, Adenot PG, Viglietta C, Baratte M, Boulanger L, Renard JP. (2002) Cloned rabbits produced by nuclear transfer from adult somatic cells. Nat Biotechnol 20: 366–369.

    Article  PubMed  Google Scholar 

  • Chrenek P, Ryban L, Vetr H, Makarevich AV, Uhrin P, Paleyanda RK, Binder BR. (2007) Expression of recombinant human factor VIII in milk of several generations of transgenic rabbits. Transgenic Res 16: 353–361.

    Article  PubMed  CAS  Google Scholar 

  • Coulibaly S, Besenfelder U, Fleischmann M, Zinovieva N, Grossmann A, Wozny M, Bartke I, Tögel M, Müller M, Brem G. (1999) Human nerve growth factor beta (hNGF-beta): mammary gland specific expression and production in transgenic rabbits. FEBS Lett 444: 111–116.

    Article  PubMed  CAS  Google Scholar 

  • Coulibaly S, Besenfelder U, Miller I, Zinovieva N, Lassnig C, Kotler T, Jameson JL, Gemeiner M, Müller M, Brem G. (2002) Expression and characterization of functional recombinant bovine follicle-stimulating hormone (boFSHalpha/beta) produced in the milk of transgenic rabbits. Mol Reprod Dev 63: 300–308.

    Article  PubMed  CAS  Google Scholar 

  • Edmunds T, Van Patten SM, Pollock J, Hanson E, Bernasconi R, Higgins E, Manavalan P, Ziomek C, Meade H, McPherson JM, Cole ES. (1998) Transgenically produced human antithrombin: structural and functional comparison to human plasma-derived antithrombin. Blood 91: 4561–4571.

    PubMed  CAS  Google Scholar 

  • Galet C, Le Bourhis CM, Chopineau M, Le Griec G, Perrin A, Magallon T, Attal J, Viglietta C, Houdebine LM, Guillou F. (2001) Expression of a single betaalpha chain protein of equine LH/CG in milk of transgenic rabbits and its biological activity. Mol Cell Endocrinol 174: 31–40.

    Article  PubMed  CAS  Google Scholar 

  • Giraldo P, Rival-Gervier S, Houdebine LM, Montoliu L. (2003) The potential benefits of insulators on heterogonous constructs in transgenic. Transgenic Res 12: 751–755.

    Article  PubMed  CAS  Google Scholar 

  • Gordon K, Lee E, Vitale JA, Smith AE, Westphal H, Hennighausen L. (1987) Production of human tissue plasminogen activator in transgenic mouse milk. Bio/Technol 5: 1183–1187.

    Article  CAS  Google Scholar 

  • Hammer RE, Pursel VG, Rexroad CE Jr, Wall RJ, Bolt DJ, Ebert KM, Palmiter RD, Brinster RL. (1985) Production of transgenic rabbits, sheep and pigs by microinjection. Nature 315: 680–683.

    Article  PubMed  CAS  Google Scholar 

  • Han J Y. (2008) Germ cells and transgenesis in chicken. Comp Immunol Microbiol Infect Dis 32: 61–80.

    Article  PubMed  Google Scholar 

  • Houdebine LM. (2002) Antibody manufacture in transgenic animals, comparisons with other systems. Curr Opin Biotechnol 13: 625–629.

    Article  PubMed  CAS  Google Scholar 

  • Houdebine LM. (2007) Transgenic animal models and target validation. Meth Mol Biol 360: 163–202.

    CAS  Google Scholar 

  • Houdebine LM. (2008) Methods to generate transgenic animals in ethics of science and technology assessment. Springer. Heildelberg/Berlin/New York 34: 31–48.

    Google Scholar 

  • Houdebine LM. (2009) Production of pharmaceutical proteins by transgenic animals. Comparative Immunology, Microbiology & Infectious Diseases 32: 107–121.

    Article  Google Scholar 

  • Jeffris R (2006) A sugar switch for anti-inflammatory antibodies Nat Biotechnol 24: 1230–1231.

    Article  Google Scholar 

  • Korhonen VP, Tolvanen M, Hyttinen JM, Uusi-Oukari M, Sinervirta R, Alhonen L, M, Jänne OA, Jänne J. (1997) Expression of bovine beta-lactoglobulin/human erythropoietin fusion protein in the milk of transgenic mice and rabbits. Eur J Biochem. 245: 482–489.

    Article  PubMed  CAS  Google Scholar 

  • Koles K, van Berkel PH, Pieper FR, Nuijens JH, Mannesse ML, Vliegenthart JF, Kamerling JP. (2004a) N- and O-glycans of recombinant human C1 inhibitor expressed in the milk of trans-genic rabbits. Glycobiology 14: 51–64.

    Article  CAS  Google Scholar 

  • Koles K, van Berkel PH, Mannesse ML, Zoetemelk R, Vliegenthart JF, Kamerling JP. (2004b) Influence of lactation parameters on the N-glycosylation of recombinant human C1 inhibitor isolated from the milk of transgenic rabbits. Glycobiology 14: 979–986.

    Article  CAS  Google Scholar 

  • Lillico SG, Sherman A, McGrew MJ, Robertson CD, Smith J, Haslam C, Barnard P, Radcliffe PA, Mitrophanous KA, Elliot EA, Sang HM. (2007) Oviduct-specific expression of two therapeutic proteins in transgenic hens. Proc Natl Acad Sci U S A 104: 1771–1776.

    Article  PubMed  CAS  Google Scholar 

  • Limonta J, Pedraza A, Rodriguez A, Freyre FM, Barral AM, Castro FO, et al. (1995) Production of active anti-CD6 mouse/human chimeric antibodies in the milk of transgenic mice. Immunotech 1: 107–113.

    Article  CAS  Google Scholar 

  • Massoud M, Bischoff R, Dalemans W, Pointu H, Attal J, Schultz H, Clesse D, Stinnakre MG, Pavirani A, Houdebine LM. (1991) Expression of active recombinant human alpha 1-antitrypsin in transgenic rabbits. J Biotechnol 18: 193–203.

    Article  PubMed  CAS  Google Scholar 

  • Massoud M, Attal J, Thépot D, Pointu H, Stinnakre MG, Théron MC, Lopez C, Houdebine LM. (1996) The deleterious effects of human erythropoietin gene driven by the rabbit whey acidic protein gene promoter in transgenic rabbits. Reprod Nutr Dev 36: 555–563.

    Article  PubMed  CAS  Google Scholar 

  • McKee C, Gibson A, Dalrymple M, Emslie L, Garner I, Cottingham I. (1998) Production of biologically active salmon calcitonin in the milk of transgenic rabbits. Nat Biotechnol 16: 647–651.

    Article  PubMed  CAS  Google Scholar 

  • Millot B, Fontaine ML, Thépot D and Devinoy E. (2001) A distal region, hypersensitive to DNase I, plays a key role in regulating rabbit whey acidic protein gene expression. Biochem J 359: 557–565.

    Article  PubMed  CAS  Google Scholar 

  • Moreira PN, Pozueta J, Pérez-Crespo M, Valdivieso F, Gutiérrez-Adán A, Montoliu L. (2007) Improving the generation of genomic-type transgenic mice by ICSI. Transgenic Res 16: 163–168.

    Article  PubMed  CAS  Google Scholar 

  • Palmiter RD, Brinster RL, Hammer RE, Trumbauer ME, Rosenfeld MG, Birnberg NC, Evans RM. (1982) Dramatic growth of mice that develop from eggs microinjected with metallothionein-growth hormone fusion genes. Nature 300: 611–615.

    Article  PubMed  CAS  Google Scholar 

  • Pera MF, Hasegawa K. (2008) Simpler and safer cell reprogramming. Nat Biotechnol 26: 59–60.

    Article  PubMed  CAS  Google Scholar 

  • Rival S, Attal J, Delville-Giraud C, Yerle M, Laffont P, Rogel-Gaillard C, Houdebine LM. (2001) Cloning, transcription and chromosomal localization of the porcine whey acidic protein gene and its expression in HC11 cell line. Gene 267: 37–47.

    Article  PubMed  CAS  Google Scholar 

  • Rival-Gervier S, Viglietta C, Maeder C, Attal J, Houdebine LM. (2002) Position-independent and tissue-specific expression of porcine whey acidic protein gene from a bacterial artificial chromosome in transgenic mice. Mol Reprod Dev 63: 161–167.

    Article  PubMed  CAS  Google Scholar 

  • Rival-Gervier S, Maeder C,Viglietta C, Prince S and Houdebine LM. (2003) Effect of 5'HS4 insulator on rabbit WAP gene action in transgenic mice. Transgenic Res 12: 12723–12730.

    Article  Google Scholar 

  • Rodriguez A, Castro FO, Aguilar A, Ramos B, Del Barco DG, Lleonart R, De la Fuente J. (1995) Expression of active human erythropoietin in the mammary gland of lactating transgenic mice and rabbits. Biol Res 28: 141–153.

    PubMed  CAS  Google Scholar 

  • Saidi S, Rival-Gervier S, Daniel-Carlier N, Thépot D, Morgenthaler C, Viglietta C, Prince S, Passet B, Houdebine LM and Jolivet G. (2007) Distal control of the pig whey acidic protein (WAP) locus in transgenic mice. Gene 401: 97–107.

    Article  PubMed  CAS  Google Scholar 

  • Shen W, Li L, Pan Q, Min L, Dong H, Deng J. (2006) Efficient and simple production of trans-genic mice and rabbits using the new DMSO-sperm mediated exogenous DNA transfer method. Mol Reprod Dev 73: 589–594.

    Article  PubMed  CAS  Google Scholar 

  • Shinohara ET, Kaminski JM, Segal DJ, Pelczar P, Kolhe R, Ryan T, Coates CJ, Fraser MJ, Handler AM, Yanagimachi R, Moisyadi S. (2007) Active integration: new strategies for trans-genesis. Transgenic Res 16: 333–339.

    Article  PubMed  CAS  Google Scholar 

  • Smith K, Spadafora C. (2005) Sperm mediated gene transfer: applications and implications. BioEssays 27: 551–562.

    Article  PubMed  CAS  Google Scholar 

  • Soler E, Le Saux A, Guinut F, Passet B, Cohen R, Merle C, Charpilienne A, Fourgeux C, Sorel V, Piriou A, Schwartz-Cornil I, Cohen J, and Houdebine LM. (2005) Production of two vaccinating recombinant rotavirus proteins in the milk of transgenic rabbits. Transgenic Res 14: 833–844.

    Article  PubMed  CAS  Google Scholar 

  • Strömqvist M, Houdebine LM, Andersson JO, Edlund A, Johansson T, Viglietta C, Puissant C, Hansson L. (1996) Recombinant human extracellular superoxide dismutase produced in milk of transgenic rabbits. Transgenic Res 6: 271–278.

    Article  Google Scholar 

  • Van de Lavoir MC, Diamond JH, Leighton PA, Mather-Love C, Heyer BS, Bradshaw R, Kerchner A, Hooi LT, Gessara TM, Swanberg SE, Delany ME, Etches RJ. (2006) Germline transmission of genetically modified primordial germ cells. Nature 441: 766–769.

    Article  PubMed  Google Scholar 

  • Weidle UH, Lenz H, Brem G. (1991) Genes encoding a mouse monoclonal antibody are expressed in transgenic mice, rabbits and pigs. Gene 98: 185–191.

    Article  PubMed  CAS  Google Scholar 

  • Wolf E, Jehle PM, Weber MM, Sauerwein H, Daxenberger A, Breier BH, Besenfelder U, Frenyo L, Brem G (1997) Human insulin-like growth factor I (IGF-I) produced in the mammary glands of transgenic rabbits: yield, receptor binding, mitogenic activity, and effects on IGF-binding proteins.Endocrinology 138: 307–313.

    Article  PubMed  CAS  Google Scholar 

  • Yong HY, Hao Y, Lai L, Li R, Murphy CN, Rieke A, Wax D, Samuel M, Prather RS. (2006) Production of a transgenic piglet by a sperm injection technique in which no chemical or physical treatments were used for oocytes or sperm. Mol Reprod Dev 73: 595–599.

    Article  PubMed  CAS  Google Scholar 

  • Zinovieva N, Lassnig C, Schams D, Besenfelder U, Wolf E, Müller S, Frenyo L, Seregi J, Müller M, Brem G. (1998) Stable production of human insulin-like growth factor 1 (IGF-1) in the milk of hemi- and homozygous transgenic rabbits over several generations. Transgenic Res 7: 437–447.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. BioProtein Technologies Domaine de Vilvert, Jouy en Josas, 78350, France

    Pierre-Jean Ripoll

Authors
  1. Louis-Marie Houdebine
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Geneviève Jolivet
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Pierre-Jean Ripoll
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Institute of Research in Agronomy, Jouy en Josas, France

    Louis-Marie Houdebine (Doctor) (Doctor)

  2. Department of Molecular Pathology, Interdisciplinary Graduate, School of Medicine and Engineering, University of Yamanashi, Yamanashi, Japan

    Jianglin Fan (Chairman and Professor) (Chairman and Professor)

Rights and permissions

Reprints and permissions

Copyright information

© 2009 Springer Science + Business Media B.V.

About this chapter

Cite this chapter

Houdebine, LM., Jolivet, G., Ripoll, PJ. (2009). Transgenic Rabbits to Prepare Pharmaceutical Proteins. In: Houdebine, LM., Fan, J. (eds) Rabbit Biotechnology. Springer, Dordrecht. https://doi.org/10.1007/978-90-481-2227-1_8

Download citation

Publish with us

Policies and ethics

Search

Navigation